DNA Synthesizer Market (2026 - 2033)

DNA Synthesizer Market Summary

The global DNA synthesizer market size was valued at USD 386.8 million in 2025 and is projected to grow from USD 419.7 million in 2026 to USD 748.2 million by 2033, at a CAGR of 8.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 34.5% in 2025. The increasing demand for efficient DNA synthesizers from life science laboratories, and pharmaceutical & biotechnology companies is the major factor driving the market. In addition, advancements in genomics and life sciences, coupled with an increase in the importance of DNA synthesizers in synthetic and molecular biology, are other factors supporting market expansion. Rising demand for novel synthesis technologies and technological advancements are the major factors driving the global market.

Improvements in nucleic acid synthesis methods have opened new avenues for market participants. For instance, the SYNTAX STX-100 system developed by DNA Script is the first DNA printer powered by enzymatic synthesis, enabling on-demand synthesis of custom oligos in a benchtop solution. Moreover, such synthesizers are equipped with enhanced speed and flexibility modules that enable technicians to create custom oligos in less time.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Increasing demand for benchtop DNA synthesizers, owing to their ability to increase speed & efficiency of research in academic and industrial labs, is projected contribute to market growth. Thus, the rise in demand for benchtop solutions is pushing manufacturers to develop reliable benchtop systems. For instance, in January 2025, Aldevron introduced Alchemy Cell-Free DNA Technology, the newest generation enzymatic DNA manufacturing platform for the production of linear DNA templates used for IVT and mRNA synthesis. With over 50% less time to manufacture the DNA and high purity of the DNA templates, it is expected to facilitate the workflow for genomic medicine, synthetic biology, and molecular biology applications.

The DNA synthesizer market is witnessing substantial growth due to the increasing adoption of synthetic biology, genomics research, and molecular diagnostics across the healthcare and life sciences sectors. DNA synthesizers are an important instrument to synthesize short DNA sequences for use in gene editing, genetic engineering, drug development, and vaccine creation, as well as modern biological research. The emphasis on precise medicine and personalized therapeutics has augmented the demand for efficient and correct DNA synthesis technology. Increasing investment in biotechnology research, the wide range of applications of genomics, and the development of automation systems have encouraged labs to use high-throughput DNA synthesis platforms. Increasing research processes around the world are expected to increase the market growth of reliable DNA synthesizers through the prediction period.

The increasing adoption of synthetic biology, genomics, and genetic engineering technologies is a major factor driving the growth of the DNA synthesizer market. DNA synthesizers are key devices that enable the synthesis of synthetic oligonucleotides, genes, and nucleic acid sequences, which are indispensable for molecular biology research, drug discovery, diagnostics, and biotechnology applications. The explosive growth of next-generation sequencing (NGS), CRISPR gene editing, personalized medicine, and mRNA therapeutics has also resulted in a surge in the need for high-throughput and accurate DNA synthesis platforms. In addition, the increasing investments from government organizations, research institutes, and biotechnology companies in genome research and synthetic biology programs are driving the use of high-performance DNA synthesizers. The growing need for rapid and cost-effective nucleic acid production is expected to further accelerate market growth.

Analyst Perspective

The DNA synthesizer market is expected to witness strong growth over the coming years, supported by increasing research activities in genomics, synthetic biology, and molecular medicine. Pharmaceutical, biotech, and research academic organizations require rapid customization of DNA sequences. Market growth is driven by the rising interest in gene therapy, mRNA-based drugs, and genome engineering techniques. Additionally, technological innovations have helped researchers attain a higher output while limiting operational difficulties through automation and accurate synthesis. Companies are dedicated to developing next-generation DNA synthesizers, which have speedier turnover rates, higher outputs, and synthesis accuracy. AI and high-technology software are expected to assist workflow, facilitating large-scale research. Increased use of synthetic DNA in various medical, agriculture, and industrial biotech applications, is likely to present major market opportunities for manufacturers and tech developers in the coming years.

Type Insights

The benchtop DNA synthesizers segment dominated the market in 2025 with a market share of approximately 68.5%. Factors such as increasing investment in R&D, growing demand for custom DNA synthesis, and robust demand from a large range of End-users are projected to drive segment growth. In addition, the cost-effectiveness of benchtop models is another factor responsible for their higher revenue share. Benchtop models are small in size and less expensive than those of pilot scale synthesizers, thus making them more feasible for small companies and research laboratories. Moreover, these synthesizers are commonly used for applications such as PCR mutagenesis, gene cloning, and site-directed mutagenesis. Recent advancements in synthetic biology & genetics, recent product launches, and supportive government legislation are further driving the demand for synthesizers.

The large-scale DNA synthesizers segment is expected to record a significant CAGR from 2026 to 2033. Robust demand from pharmaceutical & biotechnology companies, advances in DNA sequencing technologies, and the rising need for high-throughput screening are projected to fuel segment growth. The large-scale synthesizers are being increasingly used for high-throughput screening in drug discovery, and this is likely to provide lucrative growth opportunities for the segment.

Application Insights

The drug discovery and development segment was the leading segment in 2025 with a revenue share of about 44.0%. Wide application scope of DNA synthesizers in drug discovery, technology advancements, rising adoption of high-throughput technology, and presence of a large number of market players with robust product portfolios are projected to fuel segment growth. Moreover, rising demand for advanced synthesis tools from drug companies to facilitate efficiency is another factor supporting segment expansion.

The genetic engineering segment is projected to exhibit the fastest CAGR over the forecast period. Advancements in genetic engineering, rising availability of gene editing techniques such as CRISPR/Cas9, and rising funding for commercializing novel interventions in genetic engineering are fueling segment growth. The expansion of this particular market segment is anticipated to be significantly accelerated by the increasing availability of a variety of compact and laboratory-scale synthesizers.

End Use Insights

The pharmaceutical and biotechnology companies segment held the highest revenue share of about 48.0% in 2025. The majority of pharma and biotech companies use synthetic DNA for developing novel genetic therapies and for the drug discovery process. Thus, the demand for synthesizers from biotechnology and pharmaceutical companies is projected to increase significantly in the coming years due to the rising need for precision medicine and novel therapeutic approaches. Moreover, leading market players emphasize the development and implementation of novel platforms that can foster synthesis, which is another factor propelling segment growth.

The academic and research institutes segment is expected to expand at a notable CAGR from 2026 to 2033. Growing areas of research interest, ongoing efforts to develop novel synthesizers with higher yield capabilities, and collaboration between companies and research institutions are the key factors responsible for the growth of the segment. For instance, in January 2026, IDT and Ansa Biotechnologies formed a strategic collaboration in which Ansa's patented enzyme-based DNA synthesis platform was integrated into the IDT synthetic biology portfolio. The technology facilitates the synthesis of complex DNA constructs of up to 50 kb and is expected to enhance the speed, accuracy, and reliability of next-generation cell and gene therapy, vaccine discovery, and synthetic biology products.

Regional Insights

North America accounted for the largest market share of approximately 34.5% in 2025. The presence of a large number of market players and various developments are the key factors driving the region’s growth. Moreover, technological advancements, high investment in R&D, and rising demand for innovative synthesizers are other factors supporting the regional market. The investments by market participants in the region are on the rise, favoring the growth of DNA synthesizer market in North America.

To learn more about this report, Download Free Sample Report

Asia Pacific DNA Synthesizer Market Trends

Asia Pacific is estimated to expand at the fastest CAGR from 2026 to 2033. This can be attributed to the surge in interest in synthetic biology research, coupled with rising R&D efforts for the development of effective therapeutics. Moreover, APAC has a significant incidence of diseases due to lifestyle changes. Improving healthcare infrastructure, the entry of large biotechnology organizations, and rising investments by market players in this region are also expected to contribute to the growth in demand for synthesizers.

Key DNA Synthesizer Companies Insights

Several major companies are vying for a higher market share in the highly competitive DNA synthesizer market. Major key companies are undertaking strategic activities such as mergers, acquisitions, and alliances to elevate their market position. Companies are investing resources in research and development to improve the precision, volume, automation, and cost-effectiveness of synthesis. Strategic partnerships with biotech companies, research institutions, and academic groups likely to advance the innovation and commercialization of products.

Key DNA Synthesizer Companies:

The following key companies have been profiled for this study on the DNA synthesizer market.

• Danaher

• Twist Bioscience

• Kilobaser

• LGC Limited

• CSBio

• K&A Labs GmbH

• DNA Script

• OligoMaker ApS

• PolyGen GmbH

• Biolytic Lab Performance Inc.

Recent Developments:

• In December 2025, Twist Bioscience launched new research-grade Plasmid DNA Prep solutions for research on gene therapy, nucleic acid therapeutics, and synthetic biology.

• In September 2025, Twist Bioscience partnered with Synthetic Design Lab (SDL) to enable the development of next-gen engineered therapeutics by leveraging Twist's high-throughput DNA synthesis and screening abilities.

• In April 2025, Biosearch Technologies, the genome sequencing component of LGC, entered into a collaboration with Dynamic Devices with a view to automating liquid handling solutions for integration with genomics and DNA workflows, aimed at improving high-throughput DNA processing and DNA synthesis-related workflow processes.

• In March 2025, IDT collaborated with Elegen and introduced early access to the ENFINIA Plasmid DNA, which provides long, complex DNA up to 15 kb and quickly synthesizes it in synthetic biology.

Global DNA Synthesizer Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global DNA Synthesizer Market report based on type, application, end-use, and region:

• Type Scope Outlook (Revenue, USD Million, 2021 - 2033)

  • Benchtop DNA Synthesizers

  • Large-scale DNA Synthesizers

• Application Scope Outlook (Revenue, USD Million, 2021 - 2033)

  • Drug Discovery & Development

  • Genetic Engineering

  • Clinical Diagnostics

• End-use Scope Outlook (Revenue, USD Million, 2021 - 2033)

  • Academic & Research Institutes

  • Pharmaceutical & Biotechnology Companies

  • Clinical Laboratories

• Regional Scope Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait